Univariate and multivariate analysis were performed, but neither outcome—normalization of prolactin levels or tumor size reduction—was significantly associated with factors like sex, age, initial tumor size, treatment duration, or type of germline MEN1 PV (Supplementary Table 4). The gene discussed is PRL; the disease is neoplasm.